Expert: NIH’s Policy of Sex as a Biological Variable Has Led to Greater Inclusion of Women in Clinical Research
Sarah Temkin, MD, associate director for clinical research in the Office of Research on Women’s Health (ORWH) at the National Institutes of Health (NIH), discusses some of NIH ORWH’s upcoming goals and projects on the horizon that may impact the pharmacy field.
Pharmacy Times interviewed Sarah Temkin, MD, associate director for clinical research in the Office of Research on Women’s Health (ORWH) at the National Institutes of Health (NIH). Temkin was recently a keynote speaker at the Sex and Gender Health Education Summit, which looked to address the current progress to transform medical education and health care training.
During this discussion, Temkin addresses some upcoming goals and projects on the horizon for the NIH ORWH that may impact the pharmacy field.
